| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Resources and information for cancer survivors in the greater New Orleans area.
Showing posts with label ovarian cancer. Show all posts
Showing posts with label ovarian cancer. Show all posts
Wednesday, September 4, 2019
September is Ovarian Cancer Awareness Month
Tuesday, September 25, 2018
Are You at Risk for Ovarian Cancer?
New post on Living Well |
|
Know the Risk Factors
The exact causes of ovarian cancer are unknown. But the following factors can play a role:
- Increasing Age: Being middle-aged or older increases the odds of developing ovarian cancer. Risk is highest after menopause. The average age at diagnosis of ovarian cancer in the S. is 63 years old.
- Family history: A woman may be at risk if she has a first-degree relative—that is, a daughter, sister, or mother—who has had ovarian cancer. Her risk is particularly high if two or more first-degree relatives have had this cancer. A history of the disease in other close family members—such as aunts or grandmothers, on either your mother’s or father’s side—is also linked to a higher-than-average risk.
A family history of breast or colon cancer also has been associated with an increased risk of ovarian cancer. Moreover, women who have a strong family history of breast cancer sometimes opt to get checked for the BRCA1 or BRCA2 genes, which are linked to a high risk of breast cancer. Being a carrier of either one of these genes is associated with an increased risk of ovarian cancer. However, it is important to note, however, majority of women who develop ovarian cancer has no family history of ovarian cancer and no genetic mutation.
- Personal history: Women who have had colon or breast cancer may face a higher risk for ovarian cancer than those who have not had either of these other cancers.
- Infertility and Endometriosis: Women who have never given birth have a higher risk than women who have. In fact, the more children women have had, the less apt they are to get ovarian cancer.
- Talcum Powder: In some studies, use of talcum powder in feminine hygiene products or contraceptives has been linked to ovarian cancer. However, the overall increase in risk is minimal. This issue is still being explored.
Factors that are associated with a decreased risk include: previous pregnancy, history of breast feeding, oral contraceptives and tubal ligation.
Warning Signs
If detected early, ovarian cancer is treatable. But symptoms often are vague and may not show up until later stages of the cancer. Easy-to-overlook warning signs may include:
- Stomach discomfort, such as indigestion, nausea, swelling, or cramps
- Diarrhea, constipation, or frequent urination
- Decreased appetite
- Feeling full after even a light meal
- Unexplained weight gain or loss
- Abnormal vaginal bleeding
- Pain during intercourse
- Fatigue
- Backache
Its' important to pay attention and talk to your doctor if these “vague” symptoms become persistent and/or increased in frequency, intensity and duration. A patient with ovarian cancer has the best chance of being cured when she is treated early.
Click here to learn more about Ovarian Cancer.
Dr. Cheng, who served as a faculty member at Tulane Medical School before joining Touro’s Crescent City Physicians group in 2007, treats gynecologic cancers such as endometrial, cervical, ovarian and vulva cancers, as well as other complex gynecologic issues that require specialized surgical skills, including robotic surgery.
|
Unsubscribe to no longer receive posts from Living Well.
Change your email settings at Manage Subscriptions.
Trouble clicking? Copy and paste this URL into your browser:
https://livingwellblog.co/ |
Tuesday, January 16, 2018
Invasive ovarian cancer risk: understanding the role of the menstrual cycle
Ovarian cancer is the tenth most common form of cancer among women in the United States, but it accounts for more deaths than any other cancer of the female reproductive system. If detected early, the 5-year survival rate is greater than 90%; however, a majority of ovarian cancer cases are diagnosed at a late stage. Thus, better understanding of ovarian cancer risk factors may have a significant public health impact. Researchers in the Public Health Sciences Division recently published a paper in Cancer Epidemiology, Biomarkers & Prevention of a study that carefully assessed the relationship between ovarian cancer risk and certain characteristics of the menstrual cycle.
Tuesday, January 2, 2018
Tuesday, December 26, 2017
Monday, September 18, 2017
LET’S TALK. GLOBAL TEAL TALK DAY FOR OVARIAN CANCER
BY:
September 23 is Global Teal Talk Day, founded by Ovarcome. Over 249,000 women are diagnosed annually with ovarian cancer, worldwide. Gather your friends, wear teal for a day out together and talk.
Join a group of co-workers for lunch. Men are welcome, also. They have mothers, wives, daughters and sisters at risk for ovarian cancer. They should have the Teal Talk, too! There is no standard screening for ovarian cancer. In absence of a test, awareness is best. In the hour it might take to have the Teal Talk during lunch, approximately 28 women would have been diagnosed with ovarian cancer.
Invite your closest friends, neighbors and sisters for drinks in the back yard. Wear your favorite teal and give the Teal Talk. Let them know early detection improves survival rates by 90%. Make sure they know the symptoms.
Go for a walk with your mom and her friends. Even if it’s a short one it will be long enough for a Teal Talk. Ask them about family history and encourage them to share it with their daughters and granddaughters. Encourage them to see their gynecologist to review family history for inherited risk factors. Families with a strong history of ovarian or breast cancer have a 15-40% lifetime risk when compared to the general population according to the National Cancer Institute.
Founder, President & CEO
Runsi Sen, founder of Ovarcome, serves as the President and CEO of the organization. Runsi lost her mother to ovarian cancer in 2009, and in her memory and with her inspiration founded Ovarcome. Under Runsi’s leadership, Ovarcome has experienced significant growth both nationally and internationally.
Runsi graduated from Rice University in 2004 with an MBA in Strategy & Marketing. Runsi also holds a master’s degree in Economics. She serves as an Advisory Board member of the Blanton-Davis ovarian cancer research program at MD Anderson. Runsi received her early education and career experience internationally, in India. She lives with her husband and two children in Houston.
runsi@ovarcome.org
Runsi Sen, founder of Ovarcome, serves as the President and CEO of the organization. Runsi lost her mother to ovarian cancer in 2009, and in her memory and with her inspiration founded Ovarcome. Under Runsi’s leadership, Ovarcome has experienced significant growth both nationally and internationally.
Runsi graduated from Rice University in 2004 with an MBA in Strategy & Marketing. Runsi also holds a master’s degree in Economics. She serves as an Advisory Board member of the Blanton-Davis ovarian cancer research program at MD Anderson. Runsi received her early education and career experience internationally, in India. She lives with her husband and two children in Houston.
runsi@ovarcome.org
Thursday, September 7, 2017
Cancer Is Not Who I Am
Why one woman will not let the disease define who she is.
BY NORA MACKIN LALLY
PUBLISHED: JULY 21, 2017
You would think that I’d know the exact date of the last time I received a chemotherapy treatment, but honestly, I don’t remember.
I’m sure the day was marked on my 2010 calendar, but that calendar, like so many other reminders of that year, is long gone. The things I did keep — the hats my sister sent me, the wigs my parents helped me pick out — are shoved into the dustiest corner of my closet where I am sure to not accidentally run into them in my early morning scramble to get dressed.
It’s not that I forget that in 2009 I was diagnosed with ovarian cancer, which was removed (along with anything else that wasn’t nailed down inside me) in early 2010, with 18 weekly chemotherapy treatments following. It’s more like I just don’t think about it. Cancer is a place I visited once, and just never care to go to again. Like the panhandle of Texas. But I still have my journal from that time, with entries like this:
Subscribe to:
Posts (Atom)




